ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0515

Inverse Correlation Between Type I Interferon Pathway Activation And Unstimulated Whole Salivary Flow In Sicca Patients

Nikolaos Marketos1, Charalampos Skarlis1, Sylvia Raftopoulou1, Ada Gjyrezi2, Paul Zumbo3, Doron Betel3, Ioanna E. Stergiou4, Michael Voulgarelis4, Paraskevi Giannakakou5 and Clio Mavragani6, 1Molecular Physiology and Clinical Applications Unit, Department of Physiology, Medical School of Athens, National and Kapodistrian University of Athens, Athens, Greece, Athens, Greece, 2Department of Medicine, Weill Cornell Medicine, New York, NY, USA, and Department of Physiology , National & Kapodistrian University of Athens, Athens, Greece, New York, 3Department of Physiology & Biophysics, Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY, USA, New York, 4Outpatient Rheumatology Clinic, Department of Pathophysiology, Medical School of Athens, National and Kapodistrian University of Athens, Athens, Greece, Athens, Greece, 5Department of Medicine, Weill Cornell Medicine, New York, NY, USA, and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA, New York, 6National and Kapodistrian University of Athens, Athens, Greece

Meeting: ACR Convergence 2025

Keywords: Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0506–0521) Sjögren’s Disease – Basic & Clinical Science Poster I: Etiology, Pathogenesis, Diagnosis

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Oral and ocular dryness are hallmarks in patients with Sjögren’s disease (SjD). Given that activation of interferon (IFN) pathways has been shown to be involved in SjD pathogenesis, we aimed to explore whether demographic, clinicopathological, and laboratory features, as well as type I IFN-inducible gene expression, are associated with impaired salivary secretion in a cohort of patients presenting with sicca complaints. To exp

Methods: 623 consecutive patients with sicca symptoms that were evaluated in the Department of Physiology, Medical School of Athens, NKUA were included in this study after informed consent. Demographic, clinicopathological and laboratory data were thoroughly collected. Immune profile testing, chronic viral infections (HIV, HCV), chest X-ray and minor salivary gland (MSG) biopsy were also performed. Unstimulated whole salivary (UWS) flow rate was considered low with a threshold of ≤ 0.5 mL/5min. 110 MSG biopsies were subjected to real-time PCR to quantify IFN I and IFN II inducible genes (IFIGs). Moreover, IFIGs derived from the peripheral blood of these patients were evaluated. For ten patients with SjD, six of whom with normal and four with low UWS, besides next-generation sequencing (NGS), a pilot bulk RNA-sequencing study was performed. Total RNA was extracted from blood leukocytes, for which quality control was first performed. Statistical analysis was performed by SPSS 29.0. and bioinformatics analysis in R programming language.

Results: UWSF was inversely correlated to both type I IFIG transcripts (IFIT1: r=-0.446, p= 0.043, IFI44: r= -0.46, p=0.03, MX-1: r=-0.487, p=0.02) and IFN II (MIG: r= -0.592, p=0.006). Furthermore, this inverse correlation was detected against subjective oral dryness (r=-0.199, p=0.002), age at symptom onset (r=-0.146, p=0.046), Rose Bengal stain (r=-0.244, p=0.005), and Schirmer’s test (r=-0.339, p< 0.001). Additionally, UWSF was inversely correlated to the presence of anti-Ro/SSA (r=-0.246, p< 0.001) and anti-La/SSB (r=-0.199, p=0.003) serological reactivities, as well as ESR (r=-0.170, p=0.012), IgG (r=-0.278, p=0.003) IgA (r=-0.245, p=0.01) and C4 (r=-0.161, p=0.018). Finally, MSG biopsy parameters, such as Focus score (FS) (r=-0.370, p< 0.01, Tarpley (r=-0.381, p< 0.01) and fat score (r=-0.448, p=0.013) were also inversely correlated to UWSF. Following differential gene expression (DEG) analysis, the upregulated DEGs in patients with low UWS compared to normal UWS were subjected to gene ontology analysis (GO) (Fig.1). Interestingly, the patients with low UWS had upregulated GOs regarding innate immunity such as defense response to virus and symbiont. Additionally, an upregulation of processes, such as response to type I IFN and regulation of IFN production, was illustrated.

Conclusion: These data highlight a negative correlation of UWSF to components of the IFN pathway as well as demographic, laboratory, and clinicopathological features in a cohort of patients with sicca symptoms. Furthermore, SjD patients with low UWS are characterized by upregulated antiviral defense and interferon signaling pathways in their peripheral blood, highlighting the link between IFN pathway and low UWS.

Supporting image 1Figure 1-Gene Ontology (GO) analysis of upregulated genes in patients with low versus normal unstimulated salivary flow rates.


Disclosures: N. Marketos: None; C. Skarlis: None; S. Raftopoulou: None; A. Gjyrezi: None; P. Zumbo: None; D. Betel: None; I. Stergiou: None; M. Voulgarelis: None; P. Giannakakou: None; C. Mavragani: None.

To cite this abstract in AMA style:

Marketos N, Skarlis C, Raftopoulou S, Gjyrezi A, Zumbo P, Betel D, Stergiou I, Voulgarelis M, Giannakakou P, Mavragani C. Inverse Correlation Between Type I Interferon Pathway Activation And Unstimulated Whole Salivary Flow In Sicca Patients [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/inverse-correlation-between-type-i-interferon-pathway-activation-and-unstimulated-whole-salivary-flow-in-sicca-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/inverse-correlation-between-type-i-interferon-pathway-activation-and-unstimulated-whole-salivary-flow-in-sicca-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology